Driving Stability, Clinical Validity & Scalable Production of iPSC Therapies
The 5th Annual iPSC Drug Development Summit returned to Boston in 2025 as your longest standing and most definitive platform for uniting iPSC-based drug developers across the value chain, from R&D right through to CMC, to accelerate the development of genetically stable, clinically efficacious and scalable iPSC cell therapies.
The Summit tailored learning across 2 tracks of content, with a Preclinical stream, and Process Development & CMC stream – where attendees took a deep-dive into novel humanized mouse models to aid a greater translational leap into the clinic, or explore novel bioreactors for new methods of iPSC generation.
Also in attendance were the trailblazers of the iPSC field, including Aspen Neuroscience, Sana Biotech, Novo Nordisk, and BlueRock Therapeutics, as they unveiled practical strategies for engineering allo-evasive cell products, overcoming reprogramming and scalability challenges, and addressing regulatory complexities from R&D through to commercialization. Attendees learnt how leaders were optimizing iPSC line selection, advancing GMP-compliant manufacturing, and deploying novel genetic and encapsulation-based tools to stabilize differentiation outcomes and maximize clinical impact.
With therapeutic applications spanning oncology, neurology, immunology, and regenerative medicine, this summit equipped you to navigate the most pressing hurdles in iPSC development - from managing donor variability and ensuring genomic stability, to aligning QC testing with GMP standards. You gained actionable insights on optimizing iPSC-derived T cell maturation, tackling immunogenicity, standardizing differentiation protocols, and validating final cell identities to streamline delivery, satisfy regulators, and accelerate your path to clinic.
This is an amazing conference that covers both R&D and manufacturing perspectives of iSPC. The well organized program offers not only the opportunity to learn the cutting-edge technologies, but also the excellent networking opportunities with so many leaders.
Instructor, UCLA, 2024 Attendee
It was great to connect with scientists and leaders at the forefront of the pragmatic translation of iPSC research into therapeutics.
Chief Executive Officer & Co-Founder, Theseus Therapies, 2025 Speaker
This summit was a great opportunity to interact with many people, and I was very satisfied with the valuable information I gained.
Principal Researcher, DewcellBio, 2024 Attendee
Explore the Full Event Guide
- Get a full overview of the agenda, speakers, and sessions in one place
- Discover exclusive content such as keynote highlights, attendee benefits and more
- Share easily with colleagues and decision-makers to mobilize interest
Official Partners
Attending Companies Include
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.